---
title: "SINOTHERAPEUTICS: The company's products are expected to be selected for the national centralized procurement of drugs"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263229873.md"
description: "SINOTHERAPEUTICS announced that recently, the company participated in the bidding organized by the National Organization for Drug Procurement Office for the 11th batch of national centralized drug procurement. According to the \"Proposed Selection Results Announcement for National Centralized Drug Procurement\" released by the procurement office on October 28, 2025, the company's product Olaparib tablets is proposed to be selected for this centralized procurement"
datetime: "2025-10-29T07:34:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263229873.md)
  - [en](https://longbridge.com/en/news/263229873.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263229873.md)
---

# SINOTHERAPEUTICS: The company's products are expected to be selected for the national centralized procurement of drugs

SINOTHERAPEUTICS announced that the company recently participated in the bidding organized by the National Organization for Drug Procurement Office for the 11th batch of national centralized drug procurement. According to the "Public Announcement of Proposed Selected Results for National Centralized Drug Procurement" released by the procurement office on October 28, 2025, the company's product Olaparib tablets is proposed to be selected for this centralized procurement

### Related Stocks

- [688247.CN](https://longbridge.com/en/quote/688247.CN.md)

## Related News & Research

- [The $1.2tn untapped pharma opportunity in tropical conservation](https://longbridge.com/en/news/294354505.md)
- [Cold-Chain Provider Shanghai Shengsheng Renews Hong Kong Listing Plan](https://longbridge.com/en/news/294397065.md)
- [ERG (BIT:ERG) Stock Grapples With Profit Squeeze And Thin Dividend Cover](https://longbridge.com/en/news/294594304.md)
- [China Resources Pharmaceutical Moves to Become Largest Shareholder in Lier Chemical](https://longbridge.com/en/news/294273054.md)
- [BUZZ-Sleep apnea pill developer Apnimed poised to jump in debut after upsized IPO](https://longbridge.com/en/news/294533308.md)